Instinct Bio SPAC merger completion and Nasdaq debut under BIOT
SPAC merger completion and Nasdaq debut under BIOT drive 23% premarket surge
- Instinct Bio completed business combination with Relativity Acquisition Corp (ACQC)
- Combined company begins trading on Nasdaq today, July 24 2026 as BIOT and BIOTW
- Focuses on regenerative medicine longevity stem cell tech skincare wellness products
- Pro forma enterprise value approximately $288 million at closing per press release
- Announcement released July 23 highlighting vertical integration and growth in $27B+ market
- De-SPAC events often generate initial volatility and trading interest in biotech sector
- No other product news or earnings; debut itself is the primary catalyst
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.